Legal status by country
Is PT-141 with oxytocin legal?
Written by Aaron CuhaReviewed Sep 2026
How PT-141 with oxytocin is classified in the United States, United Kingdom, Australia and Canada, side by side. Each country has its own page with a direct answer, the regulator's approval status and what the classification means in practice.
All four countries, side by side
| Attribute | United States · FDA | United Kingdom · MHRA | Australia · TGA | Canada · Health Canada |
|---|---|---|---|---|
| Status | Not approved | Not approved | Not approved | Not approved |
| Classification | Not approved; research use only | Not licensed | Not approved | Not approved |
| Note | Both components exist as approved medicines for other purposes; this fixed combination is compounded or sold research use only and is not approved. | Oxytocin is licensed for obstetric use; bremelanotide is not licensed in the UK and the combination is not a licensed medicine. | None recorded | None recorded |
US FDA status: Bremelanotide is FDA approved for hypoactive sexual desire disorder in premenopausal women. Oxytocin is approved for obstetric use. The combination is not approved and there is no approved oxytocin product for sexual function.. Reviewed Sep 2026.
Related compounds
General information current as of Sep 2026, not legal advice. Classifications change; confirm with the regulator or a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships.